Take Your Trading To The Next Level. Get Started Here!

U.S. poised to approve first gene-editing treatment in breakthrough for sickle cell patients

December 7, 2023 Comments Off

The U.S. Food and Drug Administration is expected to approve exa-cel for sickle cell disease in what would become the first marketed medicine to use CRISPR.